A Review on Antitumor and Antiviral Potential of Cranberries (Vaccinium Vitis-Idaea) Origin from Bulgaria

  • Svetla G. Angelova Department of Virology, National Centre of Infectious and Parasitic Diseases (NCIPD), 44A Stoletov Blvd, 1233 Sofia, Bulgaria
  • Stefka Kr. Ivanova Department of Virology, National Centre of Infectious and Parasitic Diseases (NCIPD), 44A Stoletov Blvd, 1233 Sofia, Bulgaria
  • Ivelina Trifonova Department of Virology, National Centre of Infectious and Parasitic Diseases (NCIPD), 44A Stoletov Blvd, 1233 Sofia, Bulgaria
  • Silviya Voleva Department of Virology, National Centre of Infectious and Parasitic Diseases (NCIPD), 44A Stoletov Blvd, 1233 Sofia, Bulgaria
  • Irina Georgieva Department of Virology, National Centre of Infectious and Parasitic Diseases (NCIPD), 44A Stoletov Blvd, 1233 Sofia, Bulgaria
  • Asya Stoyanova Department of Virology, National Centre of Infectious and Parasitic Diseases (NCIPD), 44A Stoletov Blvd, 1233 Sofia, Bulgaria
  • Ivayla Dincheva AgroBioInstitute, Plant Genetic Research Group, 8 Dr.Tsankov Blvd, 1000 Sofia, Bulgaria
Keywords: Bulgarian cranberries, measles, antitumor and antiviral activity.

Abstract

A major goal in antitumor and antiviral therapy is to find active ingredients that selectively suppress the proliferation of tumor cells or inhibit viral replication and proliferation. In this connection, the antitumor and antiviral activity of natural products with proven phytochemical properties and pharmacological significance are actively investigated. A promising candidate are Bulgarian cranberries from high mountain plant populations, which are a valuable natural source of food and have proven healing properties in urinary tract infections, eye diseases and cardiovascular disorders, as well as prevention of hypertension and diabetes. The active components of Vaccinium vitis-idaea L. are polyphenols and anthocyanins which belong to classes of plant components with high antioxidant, antimicrobial, cytotoxic and antiproliferative activity. Cranberries contain a high percentage and variety of vitamins (A,  E, C,  etc.) and a number of minerals (K, Ca, Mg, P, Na). In the world regions where endemic measles outbreaks occur, for secondary prevention and avoidance of complications including blindness, WHO recommends the use of high doses of vitamin A in children under 5 years of age. Bulgarian cranberries are a valuable source of vitamins A and C.The assessement of biological activity of the individual components and fractions in the composition of the Bulgarian cranberries may help to identify substances with antitumor and/or antiviral activity that could potentially be useful in future development of new therapeutic agents.

References

[1]. Liang-Tzung Lin, Wen-Chan Hsu, Chun-Ching Lin. (2014). ‘’Antiviral Natural Products and Herbal Medicines” J Tradit Complement Med., 4(1), pp 24–35. doi: 10.4103/2225-4110.124335.
[2]. Christou. L. (2011). “The global burden of bacterial and viral zoonotic infections.” Clin Microbiol Inf., 17, pp 326–30.
[3]. Grais RF., Strebel P., Mala P., Watson J., Nandy R., Gayer M. (2011). “Measles vaccination in humanitarian emergencies: A review of recent practice“. Confl . Health., 5, pp21.
[4]. Hilleman M. R. (2001). “Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications”. Vaccine, 20, pp 651–665.
[5]. Centers for Disease Control and Prevention. (2005). “Progress in reducing measles mortality—worldwide 1999–2003”. Morb. Mortal. Wkly. Rep., 54, pp 200–203.
[6]. Marinova L., Kojouharova M., Mihneva Z., (2009). “An ongoing measles outbreak in Bulgaria, 2009”. Euro Surveill., 14(26)s.
[7]. Jansen V. A., N. Stollenwerk, H. J. Jensen, M. E. Ramsay, W. J. Edmunds, and C. J. Rhodes. (2003). “Measles outbreaks in a population with declining vaccine uptake”. Science, 301, pp 804.
[8]. Locarnini S.A., Yuen L. (2010). “Molecular genesis of drug-resistant and vaccine-escape HBV mutants”. Antivir Ther., 15, pp 451–61.
[9]. Bergman L., Beelen M.L., Gallee M.P., Hollema H., Benraadt J., van Leeuwen F.E. ( 2000). “Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group”. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. 9, 356(9233), pp 881-7.
[10]. Shoeb M. (2006). “Anticancer agents from medicinal plants”. Bangladesh J Pharmacol ., 1, pp 35-41.
[11]. Taraphdar A.K., Madhumita R., Bhattacharya RK. (2001). “Natural products as inducers of apoptosis: implication for cancer therapy and prevention”. Current Science., 80(11), pp 1387-1396.
[12]. Wang S.L., Cai B., Cui C.B., Liu H.W., Wu C.F., Yao X.S. (2004). “Diosgenin-3-O-alpha-L-rhamnopyranosyl-(1 --> 4)-beta-D-glucopyranoside obtained as a new anticancer agent from Dioscorea futschauensis induces apoptosis on human colon carcinoma HCT-15 cells via mitochondria-controlled apoptotic pathway”. J Asian Nat Prod Res., 6(2), pp 115-25.
[13]. Grajek W., Olejnik A., Sip A. (2005). “Probiotics, prebiotics and antioxidants as functional foods”. Acta Biochimica Polonica, 52(3), pp 665–671.
[14]. Nikolov S., Momekov G., Kitanov G., et al., (2007). “Exploitation of the Bulgarian flora’s biodiversity as a source of immunomodulatory and/or antineoplastic agents: current challenges and perspectives”. Biotechnol & Biotechnol Equipment, 21(4), pp 471-477.
[15]. WHO/UNICEF Joint Statement on reducing measles. (http://www.unicef.org/publications/files/WHO_UNICEF_Measles_Emer gencies.pdf.)
[16]. Hussey G.D., Klein M. (1993). “Routine high-dose vitamin A therapy for children hospitalized with measles”. J. Trop. Ped., 39, pp 342345.
[17]. Puupponen-Pimia R., Nohynek L., Alakomi H., Oksman-Caldentey K. (2005). “Bioactive berry compounds – novel tools against human pathogens”. Applied Microbiology and Biotechnology, 67, pp 8-18.
[18]. Avorn J., Monane M., Gurwitz J.H., Glynn R.J., Choodnovsky I., Lipsitz L.A. (1994). “Reduction of bacteriuria and pyuria after ingestion of cranberry juice”. JAMA, The Journal of the American Medical Association, 271, pp 751-754.
[19]. Battino M., Beekwilder J., Denoyes-Rothan B., Laimer M., McDougall G.J., Mezzetti B. (2009). “Bioactive compounds in berries relevant to human health”. Nutr Rev., 67, S145-50. doi: 10.1111/j.1753-4887.2009.00178.x.
[20]. Singh I., Gautam L.K., Kaur I.R. (2016). “Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: a randomized placebo-controlled clinical research study”. Int Urol Nephrol., 48(9), pp 1379-86
[21]. Fokina G.I., Florova T.V., Roikhel V.M., Pogodina V.V. (1991). “Experimental phytotherapy of tick-borne encephalitis”. Voprosy Virusologii, 36, pp 18-21.
[22]. Ramírez-Erosa I., Huang Y., Hickie R.A., et al., (2007). “Xanthatin and xanthinosin from the burs of Xanthium strumarium L. as potential anticancer agents”. Can J Physiol Pharmacol., 85(11), pp 1160-1172.
[23]. Bankova V. (2009). “Chemical diversity of propolis makes it a valuable source of new biologically active compounds”. Journal of ApiProduct and ApiMedical Science, 1(2), pp 23-28.
[24]. Oiknine-Djian E., Houri-Haddad Y., Weiss E.I., Ofek I., Greenbaum E., Hartshorn K., Zakay-Rones Z. (2012). “High molecular weight constituents of cranberry interfere with influenza virus neuraminidase activity in vitro”. Planta Medica, 78, pp 962-967.
[25]. Dai J., Wang G., Li W., Zhang L., Yang J., Zhao X., Chen X., Xu Y., Li K. (2012). “High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy”. Journal of Biomolecular Screening, 17, pp 605-617.
[26]. Lee H.P., Li T.M., Tsao J.Y., Fong Y.C., Tang C.H. (2012). “Curcumin induces cell apoptosis in human chondrosarcoma through extrinsic death receptor pathway”. International immunopharmacology, 13(2), pp 163-9.
[27]. Hossain M.M., Banik N.L., Ray S.K. (2012). “Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells”. Neuro Int., 61(7), pp 1102-13.
[28]. He X., Liu R.H. (2006). “Cranberry phytochemicals: isolation, structure elucidation and their antiproliferative and antioxidant activities”. J Agric Food Chem., 54, pp 7069–7074.
[29]. Kondo M. (2006). “Phytochemical studies of extracts from cranberry (Vaccinium macrocarpon) with anti-cancer, anti-fungal and cardioprotective properties”. M.S. Thesis, University of Massachusetts Dartmouth.
[30]. Neto C.C. (2007). “Cranberry and its phytochemicals: a review of in vitro anticancer studies”. J Nutr., 137, pp 186S 193S.
[31]. Dandache I., Sharif T., Auger C., Kerth - Schini V.B. (2010). “Polyphenolic Compounds Targeting p53-Family Tumor Suppressors: Current Progress and Challenges” Ilicensee InTech, Chapter 6, pp 130-165, http://dx.doi.org/10.5772/56102.
[32]. Nikolaeva-Glomb L., Mukova L., Nikolova N., Badjakov I., Dincheva I., Kondakova V., Doumanova L., Galabov A.S. (2014). “In vitro antiviral activity of a series of wild berry fruit extracts against representatives of Picorna-, Orthomyxo- and Paramyxoviridae”. Nat Prod Commun., 9(1), pp 51-4.
Published
2018-11-05
Section
Articles